CHDI
Listed here are over 1,075 publications that describe some of the research funded (in whole or in part) by CHDI Foundation. You can also view just the subset of publications that have CHDI staff as authors.
Publication Search
Title
Journal
Hintiryan H, Foster NN, Bowman I, Bay M, Song MY, Gou L, Yamashita S, Bienkowski MS, Zingg B, Zhu M, Yang XW, Shih JC, Toga AW, Dong HW
The mouse cortico-striatal projectome
Mestre TA, van Duijn E, Davis AM, Bachoud-Levi AC, Busse M, Anderson KE, Ferreira JJ, Mahlknecht P, Tumas V, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P, Members of the MDS Committee on Rating Scales Development
Rating scales for behavioral symptoms in Huntington`s disease: Critique and recommendations
Vieweg S, Ansaloni A, Wang ZM, Warner JB, Lashuel HA
An intein-based strategy for the production of tag-free Huntingtin Exon 1 proteins enables new insights into the polyglutamine dependence of Httex1 aggregation and fibril formation
Schramke S, Schuldenzucker V, Schubert R, Frank F, Wirsig M, Ott S, Motlik J, Fels M, Kemper N, Holzner E, Reilmann R
Behavioral phenotyping of minipigs transgenic for the Huntington gene
Schubert R, Frank F, Nagelmann N, Liebsch L, Schuldenzucker V, Schramke S, Wirsig M, Johnson H, Kim EY, Ott S, Holzner E, Demokritov SO, Motlik J, Faber C, Reilmann R
Neuroimaging of a minipig model of Huntington`s disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessments
Baker CR, Dominguez DJF, Stout JC, Gabery S, Churchyard A, Chua P, Egan GF, Petersen A, Georgiou-Karistianis N, Poudel GR
Subjective sleep problems in Huntington`s disease: A pilot investigation of the relationship to brain structure, neurocognitive, and neuropsychiatric function
Ochaba J, Monteys AM, O`Rourke JG, Reidling JC, Steffan JS, Davidson BL, Thompson LM
PIAS1 regulates mutant Huntingtin accumulation and Huntington`s disease-associated phenotypes in vivo
Zhang N, Bailus BJ, Ring KL, Ellerby LM
iPSC-based drug screening for Huntington's disease
Choudhury SR, Harris AF, Cabral DJ, Keeler AM, Sapp E, Ferreira JS, Gray-Edwards HL, Johnson JA, Johnson AK, Su Q, Stoica L, DiFiglia M, Aronin N, Martin DR, Gao G, Sena-Esteves M
Widespread central nervous system gene transfer and silencing after systemic delivery of novel AAV-AS vector
Kumar A, Zhang J, Tallaksen-Greene S, Crowley MR, Crossman DK, Morton AJ, Van Groen T, Kadish I, Albin RL, Lesort M, Detloff PJ
Allelic series of Huntington`s disease knock-in mice reveals expression discorrelates
Hum Mol Genet
April 15, 2016
25 (8) :1619-36
25 (8) :1619-36
PMID: 26908599
PMCID: PMC4805312
DOI: 10.1093/hmg/ddw040
Langfelder P, Cantle JP, Chatzopoulou D, Wang N, Gao F, Al-Ramahi I, Lu XH, Ramos EM, El-Zein K, Zhao Y, Deverasetty S, Tebbe A, Schaab C, Lavery DJ, Howland D, Kwak S, Botas J, Aaronson JS, Rosinski J, Coppola G, Horvath S, Yang XW
Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice
Baake V, Hart EP, Bos R, Roos RA
Participants at the Leiden site of the REGISTRY Study: a demographic approach
Munoz-Sanjuan I
Support communities involved in disease studies
Connor B, Sun Y, von Hieber D, Tang SK, Jones KS, Maucksch C
AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington's disease
Fisher SP, Schwartz MD, Wurts-Black S, Thomas AM, Chen TM, Miller MA, Palmerston JB, Kilduff TS, Morairty SR
Quantitative electroencephalographic analysis provides an early-stage indicator of disease onset and progression in the zQ175 knock-in mouse model of Huntington's disease
Wiecki TV, Antoniades CA, Stevenson A, Kennard C, Borowsky B, Owen G, Leavitt B, Roos R, Durr A, Tabrizi SJ, Frank MJ
A computational cognitive biomarker for early-stage Huntington's disease
Peng Q, Wu B, Jiang M, Jin J, Hou Z, Zheng J, Zhang J, Duan W
Characterization of behavioral, neuropathological, brain metabolic and key molecular changes in zQ175 knock-in mouse model of Huntington's disease
Keum JW, Shin A, Gillis T, Mysore JS, Abu Elneel K, Lucente D, Hadzi T, Holmans P, Jones L, Orth M, Kwak S, MacDonald ME, Gusella JF, Lee JM
The Htt CAG-expansion mutation determines age at death but not disease duration in Huntington disease
Nambron R, Silajdžić E, Kalliolia E, Ottolenghi C, Hindmarsh P, Hill NR, Costelloe SJ, Martin NG, Positano V, Watt HC, Frost C, Björkqvist M, Warner TT
A metabolic study of Huntington's disease
Benraiss A, Wang S, Herrlinger S, Li X, Chandler-Militello D, Mauceri J, Burm HB, Toner M, Osipovitch M, Jim Xu Q, Ding F, Wang F, Kang N, Kang J, Curtin PC, Brunner D, Windrem MS, Munoz-Sanjuan I, Nedergaard M, Goldman SA
Human glia can both induce and rescue aspects of disease phenotype in Huntington disease
Culver BP, DeClercq J, Dolgalev I, Yu MS, Ma B, Heguy A, Tanese N
Huntington`s Disease protein Huntingtin associates with its own mRNA
J Huntingtons Dis
January 1, 2016
5 (1) :39-51
5 (1) :39-51
PMID: 26891106
PMCID: PMC4927879
DOI: 10.3233/JHD-150177
Keogh R, Frost C, Owen G, Daniel RM, Langbehn DR, Leavitt B, Durr A, Roos RA, Landwehrmeyer GB, Reilmann R, Borowsky B, Stout J, Craufurd D, Tabrizi SJ
Medication use in early-HD participants in Track-HD: an investigation of its effects on clinical performance
Carvalho JO, Long JD, Westervelt HJ, Smith MM, Bruce JM, Kim JI, Mills JA, Paulsen JS, PREDICT-HD Investigators and Coordinators of The Huntington Study Group
The impact of oculomotor functioning on neuropsychological performance in Huntington disease
J Clin Exp Neuropsychol
January 1, 2016
38 (2) :217-26
38 (2) :217-26
PMID: 26745770
Gregory S, Cole JH, Farmer RE, Rees EM, Roos RA, Sprengelmeyer R, Durr A, Landwehrmeyer B, Zhang H, Scahill RI, Tabrizi SJ, Frost C, Hobbs NZ
Longitudinal diffusion tensor imaging shows progressive changes in white matter in Huntington's disease
Puigdellivol M, Cherubini M, Brito V, Giralt A, Suelves N, Ballesteros J, Zamora-Moratalla A, Martin ED, Eipper BA, Alberch J, Gines S
A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington`s disease
Hum Mol Genet
December 20, 2015
24 (25) :7265-85
24 (25) :7265-85
PMID: 26464483
PMCID: PMC4664166
DOI: 10.1093/hmg/ddv426
Dominguez DJF, Stout JC, Poudel G, Churchyard A, Chua P, Egan GF, Georgiou-Karistianis N
Multimodal imaging biomarkers in premanifest and early Huntington`s disease: 30-month IMAGE-HD data
Luckhurst CA, Breccia P, Stott AJ, Aziz O, Birch HL, Bürli RW, Hughes SJ, Jarvis RE, Lamers M, Leonard PM, Matthews KL, McAllister G, Pollack S, Saville-Stones E, Wishart G, Yates D, Dominguez C
Potent, selective, and CNS-penetrant tetrasubstituted cyclopropane class IIa Histone Deacetylase (HDAC) Inhibitors
Ring KL, An MC, Zhang N, O’Brien RN, Ramos EM, Gao F, Atwood R, Bailus BJ, Melov S, Mooney SD, Coppola G, Ellerby LM
Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human Huntington's disease neural stem cells
Dickey AS, Pineda VV, Tsunemi T, Liu PP, Miranda HC, Gilmore-Hall SK, Lomas N, Sampat KR, Buttgereit A, Torres MM, Flores AL, Arreola M, Arbez N, Akimov SS, Gaasterland T, Lazarowski ER, Ross CA, Yeo GW, Sopher BL, Magnuson GK, Pinkerton AB, Masliah E, La Spada AR
PPAR-delta is repressed in Huntington`s disease, is required for normal neuronal function and can be targeted therapeutically
Banez-Coronel M, Ayhan F, Tarabochia AD, Zu T, Perez BA, Tusi SK, Pletnikova O, Borchelt DR, Ross CA, Margolis RL, Yachnis AT, Troncoso JC, Ranum LP
RAN translation in Huntington disease
Liu WC, Kohn J, Szwed SK, Pariser E, Sepe S, Haripal B, Oshimori N, Marsala M, Miyanohara A, Lee R
Human mutant huntingtin disrupts vocal learning in transgenic songbirds
McColgan P, Seunarine KK, Razi A, Cole JH, Gregory S, Durr A, Roos RA, Stout JC, Landwehrmeyer B, Scahill RI, Clark CA, Rees G, Tabrizi SJ, Track-HD Investigators
Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington`s disease
Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P
Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington`s disease gene carriers
Epping EA, Kim JI, Craufurd D, Brashers-Krug TM, Anderson KE, McCusker E, Luther J, Long JD, Paulsen JS, Predict-Hd Investigators, Coordinators of the Huntington Study Group
Longitudinal psychiatric symptoms in prodromal Huntington`s disease: a decade of data
Minkova L, Eickhoff SB, Abdulkadir A, Kaller CP, Peter J, Scheller E, Lahr J, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Kloppel S, Track-HD Investigators
Large-scale brain network abnormalities in Huntington`s disease revealed by structural covariance
Long JD, Paulsen JS, Predict-HD Investigators, Coordinators of the Huntington Study Group
Multivariate prediction of motor diagnosis in Huntington`s disease: 12 years of PREDICT-HD
Lazar AS, Panin F, Goodman AO, Lazic SE, Lazar ZI, Mason SL, Rogers L, Murgatroyd PR, Watson LP, Singh P, Borowsky B, Shneerson JM, Barker RA
Sleep deficits but no metabolic deficits in premanifest Huntington`s disease
Matsui JT, Vaidya JG, Wassermann D, Kim RE, Magnotta VA, Johnson HJ, Paulsen JS, Predict-HD Investigators, Coordinators of the Huntington Study Group
Prefrontal cortex white matter tracts in prodromal Huntington disease
Hum Brain Mapp
October 1, 2015
36 (10) :3717-32
36 (10) :3717-32
PMID: 26179962
PMCID: PMC4583330
DOI: 10.1002/hbm.22835
Kim JI, Long JD, Mills JA, Downing N, Williams JK, Paulsen JS, Predict-HD Investigators, Coordinators of the Huntington Study Group
Performance of the 12-item WHODAS 2.0 in prodromal Huntington disease
Correia K, Harold D, Kim KH, Holmans P, Jones L, Orth M, Myers RH, Kwak S, Wheeler VC, MacDonald ME, Gusella JF, Lee JM
The Genetic Modifiers of Motor OnsetAge (GeM MOA) website: Genome-wide association analysis for genetic modifiers of Huntington`s disease